The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 2SEVENTY BIO INC | COMMON STOCK | 901384107 | 1,019 | 70,000 | SH | SOLE | NONE | 70,000 | 0 | 0 | |
| 8X8 INC NEW | NOTE 0.500% 2/0 | 282914AB6 | 1,279 | 1,500,000 | SH | SOLE | NONE | 1,500,000 | 0 | 0 | |
| AKERO THERAPEUTICS INC | COM | 00973Y108 | 2,213 | 65,000 | SH | SOLE | NONE | 65,000 | 0 | 0 | |
| ALIGNMENT HEALTHCARE INC | COM | 01625V104 | 1,894 | 160,000 | SH | SOLE | NONE | 160,000 | 0 | 0 | |
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 600 | 3,000 | SH | SOLE | NONE | 3,000 | 0 | 0 | |
| ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 720 | 100,000 | SH | SOLE | NONE | 100,000 | 0 | 0 | |
| ALTUS POWER INC | COM CL A | 02217A102 | 1,197 | 108,700 | SH | SOLE | NONE | 108,700 | 0 | 0 | |
| AN2 THERAPEUTICS INC | COM | 037326105 | 4,055 | 233,330 | SH | SOLE | NONE | 233,330 | 0 | 0 | |
| ARGENX SE | SPONSORED ADR | 04016X101 | 4,237 | 12,000 | SH | SOLE | NONE | 12,000 | 0 | 0 | |
| BELLUS HEALTH INC | COM NEW | 07987C204 | 317 | 30,000 | SH | SOLE | NONE | 30,000 | 0 | 0 | |
| BIOHAVEN LTD | COM | G1110E107 | 2,520 | 400,000 | SH | SOLE | NONE | 400,000 | 0 | 0 | |
| CARNIVAL CORP | COMMON STOCK | 143658300 | 2,564 | 364,666 | SH | SOLE | NONE | 364,666 | 0 | 0 | |
| CHINOOK THERAPEUTICS INC | COM | 16961L106 | 1,868 | 95,000 | SH | SOLE | NONE | 95,000 | 0 | 0 | |
| CIDARA THERAPEUTICS INC | COM | 171757107 | 232 | 369,099 | SH | SOLE | NONE | 369,099 | 0 | 0 | |
| CINCOR PHARMA INC | COM | 17240Y109 | 985 | 30,000 | SH | SOLE | NONE | 30,000 | 0 | 0 | |
| COMPASS THERAPEUTICS INC | COM | 20454B104 | 2,805 | 1,230,441 | SH | SOLE | NONE | 1,230,441 | 0 | 0 | |
| CORE & MAIN INC | CL A | 21874C102 | 2,501 | 110,000 | SH | SOLE | NONE | 110,000 | 0 | 0 | |
| COREBRIDGE FINANCIAL INC | COM | 21871X109 | 4,923 | 250,000 | SH | SOLE | NONE | 250,000 | 0 | 0 | |
| CRESCENT ENERGY INC | CL A COM | 44952J104 | 1,684 | 125,000 | SH | SOLE | NONE | 125,000 | 0 | 0 | |
| DOCGO INC | COM | 256086109 | 1,736 | 175,000 | SH | SOLE | NONE | 175,000 | 0 | 0 | |
| DYNE THERAPEUTICS INC | COM | 26818M108 | 2,540 | 200,000 | SH | SOLE | NONE | 200,000 | 0 | 0 | |
| EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 1,740 | 220,000 | SH | SOLE | NONE | 220,000 | 0 | 0 | |
| FIRST REPUBLIC BANK/CA | COM | 33616C100 | 1,306 | 10,000 | SH | SOLE | NONE | 10,000 | 0 | 0 | |
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 1,618 | 200,000 | SH | SOLE | NONE | 200,000 | 0 | 0 | |
| GOSSAMER BIO INC | COM | 38341P102 | 8,308 | 693,477 | SH | SOLE | NONE | 693,477 | 0 | 0 | |
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 895 | 60,000 | SH | SOLE | NONE | 60,000 | 0 | 0 | |
| ILLUMINA INC | NOTE 8/1 | 452327AK5 | 1,440 | 1,500,000 | SH | SOLE | NONE | 1,500,000 | 0 | 0 | |
| INVESCO QQQ | UNIT SER 1 | 46090E103 | 87,394 | 327,000 | SH | SOLE | NONE | 327,000 | 0 | 0 | |
| KNOWBE4 INC | CL A | 49926T104 | 208 | 10,000 | SH | SOLE | NONE | 10,000 | 0 | 0 | |
| LSB INDUSTRIES INC | COM | 502160104 | 449 | 31,500 | SH | SOLE | NONE | 31,500 | 0 | 0 | |
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 630 | 30,000 | SH | SOLE | NONE | 30,000 | 0 | 0 | |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 1,489 | 191,945 | SH | SOLE | NONE | 191,945 | 0 | 0 | |
| NEW RELIC INC | NOTE 0.500% 5/0 | 64829BAB6 | 491 | 500,000 | SH | SOLE | NONE | 500,000 | 0 | 0 | |
| PATRIA INVESTMENTS LTD | COM CL A | G69451105 | 392 | 30,000 | SH | SOLE | NONE | 30,000 | 0 | 0 | |
| PATRICK INDS INC | DBCV 1.000% 2/0 | 703343AB9 | 2,957 | 3,000,000 | SH | SOLE | NONE | 3,000,000 | 0 | 0 | |
| PAYCOR HCM INC | COM | 70435P102 | 1,035 | 35,000 | SH | SOLE | NONE | 35,000 | 0 | 0 | |
| PHILIP MORRIS INTERNATIONAL | COM | 718172109 | 5,396 | 65,000 | SH | SOLE | NONE | 65,000 | 0 | 0 | |
| PLIANT THERAPEUTICS INC | COM | 729139105 | 2,089 | 100,000 | SH | SOLE | NONE | 100,000 | 0 | 0 | |
| PROFRAC HOLDING CORP | CLASS A COM | 74319N100 | 1,445 | 95,000 | SH | SOLE | NONE | 95,000 | 0 | 0 | |
| RELAY THERAPEUTICS INC | COM | 75943R102 | 680 | 30,400 | SH | SOLE | NONE | 30,400 | 0 | 0 | |
| REVANCE THERAPEUTICS INC | COM | 761330109 | 2,295 | 85,000 | SH | SOLE | NONE | 85,000 | 0 | 0 | |
| SAREPTA THERAPEUTICS INC | DEBT 1.250% 9/1 | 803607AC4 | 2,078 | 2,000,000 | SH | SOLE | NONE | 2,000,000 | 0 | 0 | |
| SMARTRENT INC | COM CL A | 83193G107 | 454 | 200,000 | SH | SOLE | NONE | 200,000 | 0 | 0 | |
| SOFI TECHNOLOGIES INC | COM | 83406F102 | 1,562 | 320,000 | SH | SOLE | NONE | 320,000 | 0 | 0 | |
| SOMALOGIC INC | CLASS A COM | 83444K105 | 2,900 | 1,000,000 | SH | SOLE | NONE | 1,000,000 | 0 | 0 | |
| SPLUNK INC | NOTE 0.500% 9/1 | 848637AC8 | 3,816 | 4,000,000 | SH | SOLE | NONE | 4,000,000 | 0 | 0 | |
| SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 23 | 127,280 | SH | SOLE | NONE | 127,280 | 0 | 0 | |
| SYLVAMO CORP | COMMON STOCK | 871332102 | 3,051 | 90,000 | SH | SOLE | NONE | 90,000 | 0 | 0 | |
| THIRD HARMONIC BIO INC | COM | 88427A107 | 759 | 40,000 | SH | SOLE | NONE | 40,000 | 0 | 0 | |
| VANGUARD TOTAL STOCK MKT ETF | TOTAL STK MKT | 922908769 | 85,069 | 474,000 | SH | SOLE | NONE | 474,000 | 0 | 0 | |
| WESTERN DIGITAL CORP | NOTE 1.500% 2/0 | 958102AP0 | 2,859 | 3,000,000 | SH | SOLE | NONE | 3,000,000 | 0 | 0 | |
| WIX COM LTD | NOTE 7/0 | 92940WAB5 | 2,925 | 3,000,000 | SH | SOLE | NONE | 3,000,000 | 0 | 0 | |